We develop cutting-edge software and AI solutions for small molecule design, optimization and data analysis. Our mission is ...

The world of medicine has taken a significant leap forward with the first AI-generated drug entering clinical trials. This ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Systems and solutions that accelerate drug discovery and development workflows, today announced the expansion of its Contract ...

Gilead will integrate Interius, the first biotech to push an in vivo CAR-T therapy into the clinic, into its cell therapy subsidiary Kite.

The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has issued a ...

New in vitro results show Telomir-1 adds KDM5 family inhibition to its previously reported KDM2/KDM6 and DNA methylation activity, potentially representing a novel frontier in epigenetic therapy where ...

Therefore, the financial statements as per 30 June, 2024 consolidate the activities, revenues and cost items of Curatis AG for the months of May and June 2024, and do not take into account the 4 ...

Telomir Pharmaceuticals (TELO) announced new in vitro pharmacology results demonstrating that Telomir-1 potently inhibits three members of the ...